Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Advate
Octocog alfa 4000IU
Injection with diluent
Baxalta New Zealand Limited
Baxter Bioscience Manufacturing SARL, Neuchatel, Switzerland
Baxter AG, Vienna, Austria
|
|
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Kombiglyze
Metformin hydrochloride 500mg
Saxagliptin 2.5mg
Film coated tablet
AstraZeneca Limited
Bristol-Myers Squibb Company, Indiana, United States of America
|
|
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Kombiglyze
Metformin hydrochloride 850mg
Saxagliptin 2.5mg
Film coated tablet
AstraZeneca Limited
Bristol-Myers Squibb Company, Indiana, United States of America
|
|
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Kombiglyze
Metformin hydrochloride 1000mg
Saxagliptin 2.5mg
Film coated tablet
AstraZeneca Limited
Bristol-Myers Squibb Company, Indiana, United States of America
|
Dated this 2nd day of July 2015.
Dr DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
Gazette.govt.nz